These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4998235)

  • 1. Protected environment units for the cancer patient.
    Bodey GP; Watson P; Cooper C; Freireich EJ
    CA Cancer J Clin; 1971; 21(4):215-9. PubMed ID: 4998235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low-green environment for the overcoming of granulocytopenic stages in leukemia therapy].
    Wendt F; Grüning B; Lenz B; Brittinger G; Linzenmeier G
    Verh Dtsch Ges Inn Med; 1969; 75():916-20. PubMed ID: 4993911
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of infection with protected environment and prophylactic antibiotics in the therapy of acute leukemia.
    Nagao T; Watanabe K; Nozaki H; Komatsuda M; Arimori S
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):78-85. PubMed ID: 6797215
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient isolation units for cancer patients treated with chemical immunosuppressive agents.
    Bodey GP
    Transplant Proc; 1973 Sep; 5(3):1279-84. PubMed ID: 4199579
    [No Abstract]   [Full Text] [Related]  

  • 5. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.
    Levine AS; Siegel SE; Schreiber AD; Hauser J; Preisler H; Goldstein IM; Seidler F; Simon R; Perry S; Bennett JE; Henderson ES
    N Engl J Med; 1973 Mar; 288(10):477-83. PubMed ID: 4630706
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.
    Klastersky J; Debusscher L; Weerts D; Daneau D
    Pathol Biol (Paris); 1974 Jan; 22(1):5-12. PubMed ID: 4360753
    [No Abstract]   [Full Text] [Related]  

  • 7. Laminar air flow room reverse isolation and microbial suppression to prevent infection in patients with cancer.
    Schimpff SC
    Cancer Chemother Rep; 1975; 59(6):1055-60. PubMed ID: 816456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Germ-reducing and controlling measurements (gnotobiotics) in patients with neoplasms endangered by infections and treated with cytostatic drugs].
    Matthias M; Tanneberger S
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2074-80. PubMed ID: 4631592
    [No Abstract]   [Full Text] [Related]  

  • 9. Protected environment--prophylactic antibiotic programmes; clinical studies.
    Levine AS
    Clin Haematol; 1976 Jun; 5(2):409-24. PubMed ID: 939058
    [No Abstract]   [Full Text] [Related]  

  • 10. Protected environment units in the treatment of acute leukemia.
    Preisler HD; Bjornsson S
    Semin Oncol; 1975 Dec; 2(4):369-77. PubMed ID: 824738
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basic therapy in children with leukemias and malignant tumors. I].
    Fuchs D; Hermann J; Zintl F; Plenert W
    Kinderarztl Prax; 1977 Dec; 45(12):554-67. PubMed ID: 609199
    [No Abstract]   [Full Text] [Related]  

  • 12. Infections in cancer patients on a protected environment-prophylactic antibiotic program.
    Bodey GP; Rodriguez V
    Am J Med; 1975 Oct; 59(4):497-504. PubMed ID: 810021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection prophylaxis in granulocytopenia by clinical gnotobiotics].
    Günther I; Bohnenstengel C; Brijmohan-Günther R; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):715-20. PubMed ID: 6172339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of patients with acute leukemia and chemically-induced depression of hematopoiesis under aseptic conditions].
    Blaga M; Vaniasek Ia; Merka V; Mazak Ia; Grnchirzh Z
    Probl Gematol Pereliv Krovi; 1977 Sep; 22(9):57-8. PubMed ID: 412184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristic features of infections in hemoblastoses under cytostatic treatment (author's transl)].
    Paulisch R; Koeppen KM
    MMW Munch Med Wochenschr; 1976 May; 118(21):661-4. PubMed ID: 818543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protected environment--prophylactic antibiotic programmes; microbiological studies.
    Bodey GP; Rodriguez V
    Clin Haematol; 1976 Jun; 5(2):395-408. PubMed ID: 780031
    [No Abstract]   [Full Text] [Related]  

  • 17. [The "sterile unit" (author's transl)].
    Meunier-Carpentier F
    Rev Med Brux; 1981 Nov; 2(9):865-9. PubMed ID: 6798665
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of studies on protected environments and prophylactic antibiotics in adult acute leukemia.
    Levine AS; Robinson RA; Hauser JM
    Eur J Cancer (1965); 1975 Aug; 11suppl():57-66. PubMed ID: 815093
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isolation and intestinal sterilization in prevention of infection in patients with malignant diseases (author's transl)].
    Fernández P; Hurtado T; Cañedo T
    An Esp Pediatr; 1976 Dec; 9(9):29-36. PubMed ID: 1015688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of infection after cardiac transplantation.
    Décourt LV; Zerbini EJ
    Laval Med; 1970 Feb; 41(2):285-8. PubMed ID: 4995456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.